Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The global research community asks for the right research in the right places for COVID-19. The Global Health Network, the African Academy of Sciences and UK Collaborative on Development Research release a report in Nature that calls for the use of research evidence on the optimal implementation of public health interventions for COVID-19 in varied global settings.

Hand holding global network using modern medical and health care interface

In the absence of a vaccine and community-based treatment we are reliant on public health measures to stop this pandemic. From how to implement social distancing in urban informal settlements to how to gain trust and mitigate myths within communities. There is a clear and urgent need to further understand COVID-19.

The Global Health Network, The African Academy of Sciences and The UK Collaborative on Development Research have published findings of a global study to establish what are the remaining research priorities for COVID-19 and whether they are the same across the globe. A peer reviewed paper reporting these data has just been accepted for publication by BMJ Global, with a global perspective on this also being reported in Nature, today.

There is a finite window to undertake research within an outbreak. Scientists and researchers around the world have worked rapidly to increase understanding of COVID-19. But there are still many unknowns as the pandemic accelerates and spreads into new areas. Different studies are needed across the globe and the evidence must be tailored for different settings with the benefits from the research being equitable and widely accessible.

The full story is available on the Centre for Tropical Medicine & Global Health website

Similar stories

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.